⌘K

Login Start Free

Home/Filings/4/0001171843-17-001510

4//SEC Filing

Xenon Pharmaceuticals Inc. 4

Accession 0001171843-17-001510

$XENECIK 0001582313operating

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:28 PM ET

Size

5.3 KB

Accession

0001171843-17-001510

Insider Transaction Report

Form 4

Period: 2017-03-13

Xenon Pharmaceuticals Inc.XENE

COHEN CHARLES J.

VP, Biology

Transactions

Award
Stock Option (Right to Buy)
2017-03-13+20,000→ 20,000 total
Exercise: $8.40Exp: 2027-03-12→ Common Shares (20,000 underlying)

Footnotes (1)

[F1]Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Documents

1 file

4
f4_cohen031417.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeoperating

IncorporatedBritish Columbia, Canada

Related Parties

1

filerCIK 0001582313

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 4:28 PM ET
Size: 5.3 KB

View on SEC.gov